ID: ALA3416721

Max Phase: Preclinical

Molecular Formula: C31H35N5O4

Molecular Weight: 541.65

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)C[C@H](N)C(=O)Nc1ccc(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)OCc2ccccc2)cc1N

Standard InChI:  InChI=1S/C31H35N5O4/c1-19(2)14-25(33)30(38)35-27-13-12-21(15-24(27)32)29(37)36-28(31(39)40-18-20-8-4-3-5-9-20)16-22-17-34-26-11-7-6-10-23(22)26/h3-13,15,17,19,25,28,34H,14,16,18,32-33H2,1-2H3,(H,35,38)(H,36,37)/t25-,28-/m0/s1

Standard InChI Key:  RXOGKCBIUZQTIE-LSYYVWMOSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 541.65

Molecular Weight (Monoisotopic): 541.2689

AlogP: 4.15

#Rotatable Bonds: 11

Polar Surface Area: 152.33

Molecular Species: NEUTRAL

HBA: 6

HBD: 5

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 7

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 12.71

CX Basic pKa: 8.27

CX LogP: 4.03

CX LogD: 3.10

Aromatic Rings: 4

Heavy Atoms: 40

QED Weighted: 0.14

Np Likeness Score: -0.40

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]

Source

Source(1):

• Scientific Literature